Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$3.2 - $5.69 $182,134 - $323,857
-56,917 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$2.8 - $7.39 $159,367 - $420,616
56,917 New
56,917 $240,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.